Global Peripheral Neuropathy Treatment Market Size & Growth Analysis Report, 2020-2026

1. Orion Market Research Global Peripheral Neuropathy Treatment Market, Size, Share, Analysis Report & Forecast to 2026 Request a Free Sample of our Report on Peripheral Neuropathy Treatment Market: https://www.omrglobal.com/request-sample/peripheral-neuropathy-treatment-market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

2. The global peripheral neuropathy treatment market is estimated to grow at a CAGR of 4.3% during the forecast period. A significant rise in diabetes prevalence is the major factor in accelerating market growth. As per the International Diabetes Federation (IDF), in 2019, nearly 463 million adults (20-79 years) were suffering from diabetes, which is expected to reach 700 million by 2045. Uncontrolled high blood sugar can damage nerves and impede nerves' ability to transmit signals, which results in diabetic neuropathy. High blood sugar also impairs the walls of the capillaries (small blood vessels) that deliver the nerves with nutrients and oxygen. Peripheral neuropathy is a common type of diabetic neuropathy, which firstly affects the legs and feet, followed by the arms and hands. Get neuropathy-treatment-market Free Sample Copy @ https://www.omrglobal.com/request-sample/peripheral- It is a severe diabetic complication that may affect nearly 50% of people suffering from diabetes. This, in turn, is contributing to the demand for peripheral neuropathy treatment. The most commonly used drugs for the condition include anti-seizure drugs, antidepressants, and pain- relievers. Anti-seizure medications include pregabalin (Lyrica) and gabapentin (Gralise, Neurontin). Some antidepressants are used to ease nerve pain, even the patient is not depressed. Tricyclic antidepressants may provide relied on mild to moderate nerve pain. Drugs used for this class include desipramine (Norpramin), imipramine (Tofranil), and amitriptyline. A Full Report of Global Peripheral Neuropathy Treatment Market is Available at: https://www.omrglobal.com/industry-reports/peripheral-neuropathy-treatment-market Scope of the Global Peripheral Neuropathy Treatment Market Market Coverage •The market number available for 2019-2026 •Base year- 2019 •Forecast period- 2020-2026 •Segment Covered- By Type and Application •Regions Covered- North America, Europe, Asia-Pacific, and Rest of the World •Competitive Landscape- Pfizer Inc., Grünenthal GmbH, Novartis International AG, Eli Lilly and Co., and Daiichi Sankyo Co. Ltd. Global Peripheral Neuropathy Treatment Market-Segmentation By Type •Antidepressants •Pain Relievers •Antiseizure •Others

3. By Application •Diabetes •Chemotherapy-Induced •Others Global Peripheral Neuropathy Treatment Market– Segment by Region North America •US •Canada Europe •Germany •UK •France •Spain •Italy •Rest of Europe Asia-Pacific •China •Japan •India •Rest of Asia-Pacific Rest of the World •Latin America •Middle East and Africa For https://www.omrglobal.com/report-customization/peripheral-neuropathy-treatment- market More Customized Data, Request for Report Customization @ About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

4. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404